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Abstract 
 
Background: Holarrhena floribunda is a plant of wide usage in the Togolese folk medicine. A previous ethnobotanical 
survey on the latex plants of the Maritime region of the country revealed that this plant was included in several recipes 
curing malaria and microbial infections. Therefore, this study aimed to seek for the effectiveness of the ethanolic 
extract of the plant in the treatment of these diseases.  
Methods: The antimicrobial test was performed using the agar well-diffusion and the NCCLS broth microdilution 
methods, while the in vivo antimalarial activity was evaluated following the four-day suppressive test of Peters. The 
acute toxic effects of the extract were monitored after a single oral dose (5,000 mg/kg body weight) administration in 
NMRI mice.  
Results: The results indicated that the ethanolic extract of leaves of H. floribunda was active on Staphylococcus aureus 
ATCC 29213 and clinical strains of Staphylococcus aureus, Salmonella typhi and Klebsiella pneumoniae with MICs 
ranging from 0.62 to 1.25 mg/mL. The extract also showed significant parasitaemia suppression in a dose-dependent 
manner. In the acute toxicity assay, the oral administration of the extract to the mice did not affect the relative weight of 
vital organs, and there were no signs of toxicity or death during the study period. The LD50 of the tested extract was 
found to be greater than 5,000 mg/kg, indicating its safety.  
Conclusion: This study demonstrates the antibacterial and antimalarial activities of leaves of H. floribunda and then, 
supports its medicinal use in the treatment of microbial infections. 
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Introduction   
 
Holarrhena floribunda (G. Don) T. Durand and Schinz, is a plant belonging to the family of Apocynaceae. It 
grows as a shrub or a tree. The plant is widely distributed in West Africa, where several parts of the plant are used for 
medicinal purposes (Yemoa et al., 2015). The stem-bark and leaves are used to treat various diseases including malaria, 
fever, dysentery, amoebic diseases, diarrhoea, sterility, amenorrhea and diabetes (Bouquet & Debray, 1974; Kerharo & 
Adam, 1974; Arbonnier, 2000; Fotie et al., 2006; Bayala et al., 2006). The roots are boiled in milk and used to bathe 
boys attaining puberty in addition to cure snakebites and venereal diseases (Iwu, 2014). In our previous study on the 
latex plant used in the maritime region of Togo, we found that the decoction of the plant was administrated by oral 
route for the treatment of malaria and bacterial infections (Hoekou et al., 2016). 
Some previous pharmacological screenings showed that, the stem bark of H. floribunda was febrifuge and 
could be a quinine substitute, since it showed remarkable inhibitory activity against drug-resistant strains of 
Plasmodium falciparum. The chemical screening of the plant revealed the presence of steroid alkaloids notably 
conessine, that is used for the destruction of amoeba without emetic effects (Berhaut, 1971; Fotie et al., 2006). The 
antioxidant, antimutagenic, and lipid peroxidation inhibition potentials were also reported (Badmus et al., 2013). The 
aqueous, ethanolic, and chloroformic extracts of the stem bark of H. floribunda have been found to exhibit significant 
activity in vitro against drug-resistant clones of Plasmodium falciparum W-2 and D-6 (Fotie et al., 2006). However, the 
pharmacological properties and toxic effects of the leaves have not been intensively studied. Our study aimed to 
evaluate the in vitro antibacterial and in vivo antimalarial activities of the ethanolic extract of the leaves. Further, the 
oral acute toxicity was assayed in order to validate its therapeutic potentials.  
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Materials and Methods 
Plant materials 
 
The leaves of H. floribunda were collected from Tsévié, located at 35 km north of Lomé (Togo). The plant 
materials were obtained in October 2014 and botanically authenticated at the Department of Plant Biology and 
Ecology, University of Lomé, where a voucher specimen (voucher number TG12749) was deposited.  
 
Bacteria and parasite strains 
 
 The microorganisms used for the antibacterial tests were Gram-positive (Staphylococcus aureus ATCC 
29213 and clinical strains of Staphylococcus aureus), and Gram-negative (Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, and clinical strains of Salmonella typhi, Klebsiella pneumoniae). The ATCC 
strains were obtained from the American Type Culture Collection via National Institute of Public Health of Togo, 
whereas the clinical strains were from the laboratory of Navrongo Health Research Centre (Ghana). These strains are 
often involved in human pathology. Salmonella typhi strains were isolated from diarrhoeic stools. The clinical strains of 
S. aureus and K. pneumoniae were isolated from urine. 
The in vivo antimalarial testing in mice was done using a chloroquine sensitive strain of Plasmodium berghei 
(ANKA strain) obtained from MR4. On weekly basis, the parasites were maintained by serial passage of blood from 
infected mice having a parasitemia level of 10-15% to non-infected ones.  
 
Experimental animals 
 
Female NMRI mice (6-8 weeks and 22.92 ± 0.23 g weight) were used for the in vivo antiplasmodial test and 
female and male NMRI mice (8-10 weeks of age and 29.3 ± 1.64 g of weight) were used for acute oral toxicity assay. 
The mice were housed five per cage for in vivo antimalarial test and three per cage for toxicity assay. All the mice were 
purchased from the “Centre International de Recherche Développement sur l’Elevage en Zone Subhumide” (CIRDES), 
Bobo-Dioulasso, Burkina Faso, and acclimatised for a week prior to the start of the study. Animals were maintained in 
the same environmental conditions (temperature 24 ± 3°C and 12hours photoperiod) throughout the experiments, and 
fed with standard food provided by "Service Regional d’élevage de Bobo Dioulasso, Burkina Faso". Water and food 
were left ad libitum. Experimental animal rearing and handling were approved by the Office of Laboratory Animal 
Welfare (A5926-01) and were conducted in full adherence with NIH guidelines for care and use of Laboratory animals 
(Pub. No. 85-23, Revised 1985). 
 
Extractions 
 
The leaves of H. floribunda were washed thoroughly and dried in air at room temperature for two weeks. 
Afterwards, the plant materials were powdered using a grinding machine. The ethanolic extraction was performed by 
maceration of 100 g powder in 1000 mL of 70% (v/v) ethanol, under continuous stirring for 48 hours at room 
temperature. The extract was filtered through Whatman No.1 filter paper and evaporated at 45°C using a rotary 
evaporator to dryness under reduced pressure. The yield of the extract was 16.45%. The extract was preserved at 4°C in 
refrigerator till used. 
 
In vitro antibacterial activity  
 
The agar well-diffusion method was used to investigate the antimicrobial properties of the extracts as 
described by the National Committee for Clinical Laboratory Standards (NCCLS, 2003). The bacterial strains grown on 
nutrient agar at 37°C for 18 to 24hours were suspended in a saline solution (0.9%, w/v) to a turbidity of 0.5 Mac 
Farland standards (10
8
 CFU/mL). The suspension was used to inoculate Mueller Hinton agar, 90 mm diameter Petri 
dishes with a sterile cotton swab on a wooden applicator. A sterilized steel borer of an internal diameter of about 6 mm 
was used to bore holes in the Mueller Hinton plates. The dried ethanolic extract was dissolved in 1% dimethylsulfoxide 
at the desired concentration to fill the wells punched in the plates. Then the plates were incubated at 37°C for 24 hours. 
The antibacterial susceptibility was assessed by measuring the inhibition zone diameters around the wells (CASFM, 
2014). Ciprofloxacin (5 µg/mL) and DMSO 1% in sterilized distilled water were used as positive and negative controls 
respectively.  The Minimum Inhibitory Concentrations (MIC) and Minimal Bactericidal Concentrations (MBC) were 
determined using the Muller Hinton broth microdilution in 96 well-plates according to National Committee for Clinical 
Laboratory (NCCLS, 2003). The 0.5 Mac Farland suspensions were diluted with the broth to inoculate 96 well-plates 
containing 2-fold serial dilutions of extracts. The extract concentrations were ranged from 20 to 0.039 mg/mL, and the 
ones of standard drug, from 5 to 0.0025 µg/mL. The final volume in wells was 200 µL and the bacterial load was 
approximately 10
5
CFU/well hours. The plates were incubated at 37°C for 24 hours. The MIC was recorded as the 
lowest extract concentration demonstrating no visible growth in the broth, while the MBC was recorded as the lowest 
extract concentration killing 99.9% of the bacterial inoculums. The MBC values were determined by removing 100 µL 
of the bacterial suspension from subculture demonstrating no visible growth and inoculating the nutrient agar plates 
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that were incubated at 37°C for 24 hours. In addition to MIC, the total activity of the extract was calculated as the total 
mass in mg extracted from 1g of plant material divided by the MIC value (mg/mL). The totalactivity in mL/g indicates 
the volume to which the extract derived from g of plant material can be diluted and still inhibits the growth of the 
microorganism (Eloff, 2000). 
 
In vivo antiplasmodial activity 
 
The experiment was performed in mice based on the 4-day suppressive test (Peters & Robinson, 1992; Fidock 
et al., 2004; Tarkang et al., 2014). Five groups of five mice were used. At day 0, the mice were inoculated by intra 
peritoneal injection with 10
7
 red blood cells of donor mouse parasitized with Plasmodium berghei ANKA strain. Two 
hours later, 200 µL of plant extract at 100, 250, and 500 mg kg
-1
 body weight were administered to the animals by oral 
route once a day, from day 0 to day 3. The negative control group received the vehicle (mixture 90% distilled sterile 
water - 7% Tween 80 - 3% Ethanol) and the positive control group received chloroquine at the dose of 25 mg/kg/day. 
On the day 4, thin blood Giemsa-stained smears from each animal were examined microscopically. The parasitaemia 
level was determined by counting the number of parasitized erythrocytes out of 100 erythrocytes in random fields of 
the microscope. The parasitaemia for each group of mice was recorded and the percentage suppression of parasitaemia 
calculated as follow:  
 
The body weights of the mice were taken to observe whether the test extract prevented the weight loss in infected mice. 
The weights were measured at D0 and D4.  
 
Determination of the mean survival time 
 
The mortality was monitored daily and the number of days from the time of inoculation of the parasite up to 
death was recorded for each mouse in the treatment and control groups. The mean survival time in days for each mouse 
was recorded after the treatment periods in comparison to untreated and standard drug treated groups.  
 
Acute oral toxicity study  
 
The acute oral toxicity of ethanolic extract was evaluated according to the procedures outlined by the 
Organization for Economic Co-operation and Development (OECD, 2001). The mice were assigned randomly to the 
control and treatment groups. In each group, there were 6 mice out of which 3 males and 3 females. The treated groups 
were given oral administration using an intubation needle of H. floribunda leaves ethanolic extract at a single dose of 
5,000 mg/kg body weight suspended in a mixture of distilled sterile water - Tween 80 - ethanol (90-7-3) %, while the 
control group received the vehicle. Food and water were provided to the mice approximately an hour after treatment. 
The animals were observed 30 min after administration, followed by hourly observation for 8 hours and once a day for 
the next 13 days. Observations were systematically recorded for each animal. The mice were observed for toxic signs 
(mortality, behavioural pattern, changes in physical appearance, injury, pain and signs of illness) and the body weight 
was recorded at day 0, day 7, and day 14 throughout the 14-day study period. The animals were sacrificed on day-15 by 
an overdose of ether diethyl and were dissected to obtain the organs such as liver, heart, lungs, spleen, and kidneys for 
macroscopic examination and each organ's weight (absolute organ weight in g) was recorded. Using the following 
formula, the relative organ weight (ROW) of each organ was calculated: 
 
 
 
Data analysis 
 
The data were analyzed using the computer software SPSS, version 22. The Results were expressed as a mean 
± standard deviation. The statistical significance was determined by one way analysis of variance (ANOVA) with 
multiple comparison tests of Tukey. Two tailed paired t-test was used to compare the mean body weight before and 
after treatment. The statistical significance was set at P ≤ 0.05. 
 
Results 
Antibacterial activities 
 
Table 1 summarizes the results of the antimicrobial assays. The agar diffusion assay with the extract yielded 
inhibition diameters ranging from 0 mm to 19.5 ± 0.7 mm.  The highest inhibition was recorded with Staphylococcus 
species both the clinical strains and the reference one. This was followed by K. pneumoniae and S. typhi which 
recorded inhibition zone of 17.5 ± 0.7 mm and 14 ± 1.4 mm, respectively. E. coli ATCC 25922 and P. aeruginosa 
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ATCC 27853 resisted to the extract by displaying no inhibition zone around the wells. This result on the agar was 
confirmed by the broth microdilution. Thus, the MIC and the MBC with these strains were greater than 10 mg/mL. For 
the rest, the extract inhibited the growth of Staphylococcus species, S. typhi and K. pneumoniae with MIC values 
ranging from 0.62 to 1.25 mg/mL. The calculated total activity of the extract was 265.3 mL/g for S. aureus ATCC 
29213, and 131.6 mL/g for the clinical strains (S. aureus, K. pneumoniae and S. typhi). The reference antibiotic 
ciprofloxacin used also displayed varying diameters. It was more active on E. coli ATCC 25922 (MIC = 0.01 µg/mL) 
and less active on P. aeruginosa ATCC 27853 (MIC = 0.62 µg/mL).   
 
Table 1: Antibacterial activities of ethanolic extract of leaves of H. floribunda 
 
Bacteria  
Extract Ciprofloxacin 
IZ (mm) MIC 
(mg/mL) 
MBC 
(mg/mL) 
Total activity 
(mL/g) 
IZ (mm) MIC 
(µg/mL) 
E. coli ATCC 
25922     
0 > 10 > 10 < 16.45 29.5 ± 0.7 0.01 
P. aeruginosa 
ATCC 27853 
0 > 10 > 10  < 16.45 25 ± 0 0.62 
S. aureus ATCC 
29213 
19 ± 0 0.62 0.62 265.3 32.5 ± 2.1 0.31 
S. aureus 19.5 ± 0.7 1.25 1.25 131.6 28 ± 1.4 0.31 
S. typhi 14 ± 1.4 1.25 2.5 131.6 29 ± 1.4 0.16 
K. pneumoniae 17.5 ± 0.7 1.25 2.5 131.6 24 ± 2.8 0.16 
IZ: inhibition zones; MIC: Minimum Inhibitory Concentration; MBC: Minimal Bactericidal Concentration. 
 
Antimalarial activity  
 
The effects of the extract on the parasitaemia and the mean survival time of mice are presented in table 2. The 
extract reduced the parasitaemia for 6.96%, 29.06 and 37.71% respectively at 100, 250 and 500 mg/kg. The results 
indicated that the extract exerted a dose dependent chemosuppressive effect in mice infected with P. berghei parasite. 
The mice treated with chloroquine 25 mg/kg were completely free from the parasites after four days. The extract 
significantly suppressed (P < 0.05) the parasitaemia at all dose levels compared to the negative control group. P. 
berghei infected mice treated with extract showed a shorter survival time as compared to chloroquine treated infected 
mice. The groups of mice treated at 500 mg/kg dose of extract, and chloroquine survived significantly (P < 0.05) 
compared to negative control group.  
 
Table 2: Suppressive effect of ethanolic extract of leaves of H. floribunda and mean survival time 
 
Treatment / Extract Doses 
(mg/kg) 
Percentage 
parasitaemia 
Percentage 
inhibition 
Mean survival time 
(days) 
Negative Control (W-
Tween 80-E) 
0.2 ml 23.4 ± 2.07 0 7.64 ± 0.41 
Chloroquine 25 0 ± 0.00 100 ± 0.00* 16.15 ± 0.51* 
Ethanolic extract 100 21.8 ± 2.58 6.96 ± 2.64 7.57 ± 0.53 
250 16.6 ± 2.07 29.06 ± 5.49* 8.39 ± 0.61 
500 14.6 ± 1.82 37.71 ± 3.05* 8.81 ± 0.44* 
W-Tween 80-E = 90% of distilled sterile water + 7% Tween 80 + 3% Ethanol; n = 5; * = = values are significantly 
different as compared to the negative control. 
The body weight of the infected mice changed significantly (p < 0.05) after 4 days for the control groups and 
group treated at 250 mg/kg of extract. No significant (p > 0.05) change was observed in the body weight of groups 
treated at 100 mg/kg and 500 mg/kg of extract. The body weight measured on day 4 indicated that the tested extract of 
H. floribunda prevented significantly (P < 0.05) the body weight loss at dose levels of 250 mg/kg, and 500 mg/kg, due 
to parasitaemia. In the negative control, there was significant (P < 0.05) reduction in body weight on day 4 (Table 3). 
 
Table 3: Weight (g) of P. berghei infected mice before and after treatment in the suppressive test. 
Treatment / Extract Doses 
(mg/kg) 
Day 0 Day 4 P-value 
Negative Control (W-Tw 80- E) 0.2 ml 22.70 ± 0.97 21.89 ± 1.10 0.010 
Chloroquine 25 22.64 ± 0.64 24.77 ± 1.01 0.001 
Ethanolic extract 100 23.03 ± 1.65 22.62 ± 1.43 0.482 
250 23.09 ± 0.98 24.08 ± 1.11 0.030 
500 23.12 ± 0.84 23.76 ± 1.47 0.367 
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Acute oral toxicity  
 
To assess the acute toxic effects of the extract, 5,000 mg/kg body weight dose was orally given to male and 
female mice. There were no adverse effects throughout the 14-day study period. All the mice survived. None of the 
mice showed any signs of toxicity, such as behavioural patterns, diarrhoea, and changes on skin, falling of the fur, 
trembling, sleep or coma. All mice in the control and treatment groups showed an increase in the body weight on day-7 
and day-14 compared to day-0 (Table 4); however, the increase in body weight was not statistically significant. The 
estimated medium lethal dose (LD50) was above 5,000 mg/kg body weight for the tested extract.  
 
Table 4: Summary of body weights recorded during the acute toxicity study of H. floribunda’s leaves extract. 
Groups 
Body weight (g) 
Day 0 Day 7 Day 14 
Male Female Male Female Male Female 
Control 31.92±0.40 29±0.37 35.57±0.54 29.77±1.32 37.23±0.52 30.51±1.26 
Treatment 28.42±0.71 27.85±0.12 32.21±1.3 29.44±0.08 34.74±1.54 30.43±0.04 
The macroscopic examination did not show any significant changes in the vital organs of treated mice compared to the 
control group, indicating that the tested extract was not toxic to mice. The relative organ weight of the livers, hearts, 
lungs, spleens, and kidneys of the mice in the treatment group showed no significant changes as compared to the 
control group (Table 5). These data collectively indicated that the ethanolic extract of H. floribunda did not affect the 
vital organs of the mice.  
 
Table 5: Summary of relative organ weights (per 100 g body weight) at the end of toxicity study. 
Organs 
Control Treatment 
Male Female Male Female 
Liver 7.61 ± 0.50 4.84 ± 0.53 8.23 ± 1.46 5.35 ± 0.72 
Heart 0.69 ± 0.03 0.56 ± 0.11 0.61 ± 0.15 0.53 ± 0.13 
Lung 1.09 ± 0.12 0.85 ± 0.13 1.43 ± 0.13 0.85 ± 0.10 
Spleen 0.70 ± 0.14 0.65 ± 0.01 0.68 ± 0.21 0.67 ± 0.04 
Kidney 2.05 ± 0.04 1.23 ± 0.01 2.28 ± 0.20 1.28 ± 0.12 
Values are expressed as mean ± SD. n = 3. There is no statistically significant difference compared to control group. 
 
Discussion 
 
Holarrhena floribunda leaves are an important source of drugs used in traditional medicine to cure different 
diseases, including diabetes, malaria, cancer, and oxidant damage related diseases (Fotie et al., 2006; Badmus et al., 
2013). This study was focused on antibacterial, antimalarial activities, and acute toxicity of ethanolic extract of leaves 
of H. floribunda in order to validate its therapeutic potentials.  
For the antibacterial activity, the ethanolic extract of leaves displayed various inhibitory activities against 
tested bacteria. Equal values of MIC and MBC were found for the Staphylococcus species suggesting a bactericidal 
effect of the extract on these microorganisms. For S. typhi and K. pneumoniae the MBC was twofold the value of the 
MIC. In other words, the extract had a bacteriostatic activity against S. typhi and K. pneumoniae. The antibacterial 
activity of leaves of H. floribunda has not been well established but some previous studies showed that alkaloids from 
its stem bark inhibited the growth of E. coli with MIC equal to 0.625 mg/mL and 1.25 mg/mL according to two 
geographical zones of Burkina Faso (Kabore & Millogo, 1997). The same MICs were found in this study for the leaves 
extract against S. aureus, K. pneumoniae, and S. typhi. The crude extract and four alkaloid fractions from aerial parts of 
H. floribunda were found active against M. ulcerans (Yemoa et al., 2015). Bogne et al. (2007) found that the crude 
extracts and the alkaloids from stem bark inhibited the growth of species of the genus Bacillus, namely B. cereus, B. 
subtilis, B. megaterium and B. stearothermophilus. As MICs, the total activity of extract against Gram-positive bacteria 
(265.3 mL/g) was better than those against Gram-negative bacteria. This means that the extract from 1 g of raw 
materials could be diluted to 265.3 mL and still retains activity against the Gram-positive bacteria tested in this study.  
The present evaluation of antimalarial effect of leaves extract of H. floribunda is an additional proof of its 
medicinal values. The 4-day test using the P. berghei infected mice model is widely used as a test for the in vivo 
antiplasmodial activity of potential antimalarial agents, as it provides a preclinical indication of potential bioactivity of 
the test sample (Peters et al., 1975). According to Munoz et al. (2000), an active compound should lead at least 30% 
reduction of the parasitaemia. On this basis, the ethanolic extract of leaves of H. floribunda is active at 500 mg/kg. 
Mean survival time is another parameter evaluates the antimalarial activity of plant extracts. Accordingly, a plant 
material that can prolong the survival time of infected experimental animals compared to the negative control is 
considered as active agent against malaria (Oliveira et al., 2009). In this study, statistically, the mice treated with 500 
mg/kg of extract had significantly lived longer than negative control and this could be attributed to parasitemia 
suppression effect of the extract. The survival times of mice treated with the extract were shorter as compared to 
positive control. This may show that half-life of the active compounds in plasma metabolism is shorter (Franssen et al., 
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1997). The mice treated with chloroquine were completely free from parasites after 4 days, but survived only for 16 
days. This could be due to the toxicity of chloroquine (Phipps et al., 2011), or to any other unknown mechanisms. 
These findings on mean survival time were in agreement with similar studies (Abdulelah & Zainal-Abidin, 2007; 
Mengiste et al., 2012; Mohammed et al., 2014; Muluye et al., 2015). Previous studies showed that extracts and 
fractions from stem bark of H. floribunda had a good in vitro antiplasmodial activity against the chloroquine-resistant 
strain FCR-3 isolated from Gambia and the chloroquine-sensitive standard strain 3D7 (Fotie et al., 2006). This activity 
could be related to the plant alkaloids contents (Janot et al., 1959; Yemoa et al., 2015). According to Saxena et al. 
(2003) and Ramazani et al. (2010) several classes of secondary metabolites are responsible for the antimalarial activity, 
but the most important and diverse potential bioactivity has been observed with alkaloids. Alkaloids are one of the 
major antimalarial natural products and various classes have been reported to exhibit promising activities.  
One of the oldest and most important antimalarial drugs, quinine, belongs to this class of compounds (Mojab, 
2012). 
 For the toxicity, the evidence of safety of H. floribunda reported in the literature is limited. According to 
Garner et al. (1977), any compound or drug with an oral LD50 estimate greater than 1,000 mg/kg could be considered 
low toxic and safe. Arising from this, the ethanolic extract of H. floribunda at an oral dose of 5,000 mg/kg can be 
considered relatively safe on acute exposure. Previous studies on the toxicity of H. floribunda focused on its stem bark 
extracts. Thus, Bogne et al. (2012) in Cameroon showed that the methanolic extract of stem bark of H. floribunda is 
non-toxic with an LD50 in the range of 6,500 mg/kg and 7,000 mg/kg. These results are close to those obtained in this 
study for the leaves ethanolic extract, and confirm the non-toxicity of alcoholic extracts of H. floribunda. Therefore, in 
order to find the equivalent safe dose of ethanolic extract of leaves of H. floribunda for human consumption, the human 
equivalent dose (HED) was calculated using the following formula; which is developed based on the body surface area 
(BSA) normalization method; reported in the literature (Reagan-Shaw et al., 2007). 
 
 
Where Km factor for mouse is 3, and Km factor for human adult is 37 (Reagan-Shaw et al., 2007). 
 
 
 
From the above calculations, the leaves ethanolic extract of H. floribunda may be safe until a dose of 405.4 mg/kg bw 
for human consumption. 
 
Conclusion 
 
The present study provided evidence that the ethanolic extract of H. floribunda is safe, and demonstrated its 
antibacterial and antiplasmodial effects suggesting its pharmacological usefulness. These findings support the 
traditional usage of the plant to combat microbial infections in Togolese folk medicine. Further investigations of this 
plant are needed to isolate, identify and characterize the active compounds responsible for the observed biological 
activity of the plant. 
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